← Back to Clinical Trials
Recruiting NCT05885971

NCT05885971 Detection of Eating Disorders in Pregnant Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05885971
Status Recruiting
Phase
Sponsor Centre Hospitalier Henri Laborit
Condition Eating Disorders
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2023-06-30
Primary Completion 2026-06

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Administration of the SCOFF-F and EDE-Q questionnaires

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2023-06-30 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Eating disorders (ED) are insufficiently detected and belatedly or not treated during pregnancy. There are many screening questionnaires for eating disorders in the literature, but we note the absence of a specific and validated tool for their screening during pregnancy, which would make it possible to differentiate maternal dietary concerns related to pregnancy from symptoms linked to a proven eating disorder. The main objective of the study is to evaluate which items of the Sick Control One stone Fat Food (SCOFF-F) and Eating disorders examination questionnaire (EDE-Q) questionnaires could be specific to an ED during pregnancy and not related to the simple state of pregnancy, by comparing the answers of pregnant women, for whom the diagnosis of ED has been made, to those of pregnant women without an ED.

Eligibility Criteria

Inclusion Criteria: * Adult pregnant woman * Woman with current diagnosed Eating Disorders or without Eating Disorders * Having a good command of the French language * Having given their consent for their participation in the research Exclusion Criteria: * Underage pregnant woman * Woman who does not have a good command of the French language. * Woman with past Eating Disorders

Contact & Investigator

Central Contact

Charlotte XAVIER-DAVID

✉ charlotte.xavier-david@ch-poitiers.fr

📞 (0)5 49 52 34 93

Frequently Asked Questions

Who can join the NCT05885971 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05885971 currently recruiting?

Yes, NCT05885971 is actively recruiting participants. Contact the research team at charlotte.xavier-david@ch-poitiers.fr for enrollment information.

Where is the NCT05885971 trial being conducted?

This trial is being conducted at Poitiers, France.

Who is sponsoring the NCT05885971 clinical trial?

NCT05885971 is sponsored by Centre Hospitalier Henri Laborit. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology